CLINICAL_TRIALS
trial_result
· 2017-12-20
Clinical Trial Update: Does Doxazosin Attenuate Stress-induced Smoking and Improve Clinical Outcomes? [Phase 2]
Summary
Phase 2 trial assessing whether doxazosin reduces stress-induced smoking and improves clinical outcomes, completed with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yale University | Conditions: Smoking | Phase 2 | Status: COMPLETED | Results posted: 2017-12-20